| 141/344 | US=103 / Câncer Smith GR. Treatment of cancer in conjunction with other agents. In: Missailidis S. Anticancer therapeutics. New Jersey: Wiley Blackwell, 2008. p. 349-64. ISBN 978-0-470-72303-6. CANCER. TRATAMENTO; AGENTES ANTI-INFLAMATORIOS; AGENTES ANTI-INFECCIOSOS; CARCINOGENESE; ANTI-INFLAMATORIOS NAO-ESTEROIDES; ENZIMA CONVERSORA DE ANGIOTENSINA (ECA); BLOQUEIO DO RECEPTOR DE ANGIOTENSINA |
| 142/344 | US=14 / Câncer Siddig A, Mohamed AO, Kamal H, Awad S, Hassan AH, Zilahi E, Al-Haj M, Bernsen R, Adem A. Estrogen receptor-alpha gene polymorphism and breast cancer. In: Branicki FJ, Adem A, Ghazal-Aswad S, Torab FC. Recent advances in clinical oncology. Boston: Blackwell, 2008. p. 95-107. ISBN 978-1-57331-700-9. CANCER DE MAMA; RECEPTOR DE ESTROGENO ALFA; EXON 4; POLIMORFISMO |
| 143/344 | US=15 / Gastro Takimoto CH. Novel targets for the treatment of pancreatic cancer I: insulin-like growth factor receptor. In: Lowy AM, Leach SD, Philip PA. Pancreatic cancer. New York: Springer, 2008. p. 665-76. ISBN 978-0-387-69250-0. |
| 144/344 | US=28 / Biol/Mol Hicklin DJ. Vascular endothelial growth factor family and its receptors. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 3-26. ISBN 978-1-58829-870-6. FACTORES DE CRESCIMENTO ENDOTELIAL VASCULAR; ANGIOGENESE; CANCER; FATOR DE CRESCIMENTO; LIGANTE; NEUROPILINA; RECEPTOR; VEGF |
| 145/344 | US=28 / Biol/Mol Keane MP, Belperio JA, Strieter RM. Chemokines in angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 155-70. ISBN 978-1-58829-870-6. QUIMIOCINAS NA ANGIOGENESE; RECEPTOR QUIMIOCINAS; ANGIOGENESE; CANCER |
| 146/344 | US=23 / Câncer Frasci G, D'Aiuto G, Iodice G, Thomas R, D'Aiuto M, Comella G. Estrogen receptor-negative and HER-2/neu-positive locally advanced breast carcinoma: therapy with paclitaxel and granulocyte-colony stimulating factor. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 415-32. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CARCINOMA DE MAMA; ESTROGENIO; RECEPTOR-NEGATIVO; HER-2/NEU-POSITIVE; PACLITAXEL; COLONIAS DE GRANULOCITOS; RECEPTORES HORMONAIS; RESPOSTA A QUIMIOTERAPIA |
| 147/344 | US=23 / Câncer Shackney SE, Emlet DR, Schwartz R, Brown KA, Pollice AA, Smith CA. Breast cancer: expression of HER-2 and epidermal growth factor receptor as clinical markers for response to targeted therapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 459-82. ISBN 978-1-4020-8368-6. CANCER DE MAMA; EXPRESSAO DO RECEPTOR HER-2; FATOR DE CRESCIMENTO EPIDERMICO; RESPOSTA A TERAPIA-ALVO; IMUNOHISTOQUIMICA; HIBRIDACAO IN SITU FLUORESCENTE |
| 148/344 | US=23 / Câncer Kumar R, Lal N. 18F-Fluorodeoxyglucose/positron emission tomography in primary breast cancer: factors responsible for false-negative results. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 529-41. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TOMOGRAFIA POR EMISSAO DE POSITROS; 18F-FLUORODEOXIGLUCOSE; RESULTADOS FALSO-NEGATIVOS; TAMANHO TUMORAL; TIPO HISTOLOGICO; GRAU DO TUMOR; PADROES DE CRESCIMENTO DE TUMOR; ATIVIDADE PROLIFERATIVA; DENSIDADE DE VASOS SANGUINEOS DO TUMOR; HETEROGENEIDADE DO TECIDO; LESOES DE MAMA UNIFOCAL; LESOES DE MAMA MULTIFOCAL; RECEPTOR DE ESTROGENO; RECEPTOR DE PROGESTERONA; DENSIDADE DA MAMA; PROPAGACAO AXILAR; PROPAGACAO DISTANTE; NIVEIS DE GLICOSE NO SANGUE; TRANSPORTADORES DE GLICOSE; AQUISICAO DE DADOS; ANALISE DE DADOS |
| 149/344 | US=2 / Tórax Sequist LV, Lynch TJ. Epidermal growth factor receptor inhibitors. In: Roth JA, Cox JD, Hong WK, editors. Lung cancer. 3rd ed. Oxford: Blackwell Science, 2008. p. 352-68. ISBN 978-1-4051-5112-2. |
| 150/344 | US=23-A / Câncer Bartolazzi A. Non-small cell lung carcinoma: EGFR gene mutations and response to gefitinib. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 291-306. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; MUTACOES EGFR; GEFITINIBE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO |
| 151/344 | US=23-A / Câncer Kiura K, Takigawa N, Segawa Y. Advanced non-small cell lung carcinoma: acquired resistance to gefitinib. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 307-16. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE NAO-PEQUENAS CELULAS; CARCINOMA NAO PEQUENAS CELULAS DO PULMAO AVANCADA; RESISTENCIA A GEFITINIBE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO |
| 152/344 | US=23-A / Câncer Ma ESK, Wong CLP. Non-small cell lung cancer with brain metastasis: role of epidermal growth factor receptor gene mutation. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 371-87. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PULMAO; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; METASTASE CEREBRAL; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; MUTACAO DO GENE |
| 153/344 | US=23-A / Câncer Zanzonico P. Prostate cancer: 16B-[18F] Fluoro-5x-Dihydrotesterone (FDHT) whole-body positron emission tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: general methods and overviews, lung carcinoma and prostate carcinoma. v.2. New York: Springer, 2008. p. 521-30. ISBN 978-1-4020-8441-62. CANCER; CANCER DE PROSTATA; 16B-[18F] FLUORO-5X-DIHYDROTESTERONE (FDHT); TOMOGRAFIA POR EMISSAO DE POSITRONS; RECEPTOR DE ANDROGENO |
| 154/344 | US=23-B / Câncer Gotthardt M, Behr TM, Béhé M. Gastrointestinal neuroendocrine tumors: diagnosis using gastrin receptor scintigraphy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: gastrointestinal carcinoma. New York: Springer, 2008. p. 43-52. ISBN 978-1-4020-8899-5. CANCER; CANCER GASTROINTESTINAL; TUMORES GASTROINTESTINAIS NEUROENDOCRINOS; GASTRINA; CINTILOGRAFIA; RADIOPEPTIDE |
| 155/344 | US=29 / Imagem Baum RP, Prasad V, Hommann M, Hörsch D. Receptor PET/CT imaging of neuroendocrine tumors. In: Dresel S, editor. Pet in oncology. New York: Springer- Verlag, 2008. p. 225-42. ISBN 978-3-540-31202-4. RECEPTOR PET/CT. TUMORES NEUROENDOCRINOS; TUMORES NEUROENDOCRINOS |
| 156/344 | US=33 / Gastro Saltz LB. Systemic therapy for metastatic colorectal cancer. In: Kelsen DP, Daly JM, Kern SE, Levin B, Tepper JE, Van Cutsem E. Principles and practice of gastrointestinal oncology. 2ª ed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 617-30. ISBN 978-0-7817-7617-2. CANCER COLORRETAL METASTATICO; TERAPIA SISTEMICA; QUIMIOTERAPIA CITOTOXICA; AGENTE RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO |
| 157/344 | US=38 / Biol/Mol Uzel G. Detection and characterization of the T-cell receptor repertoire. In: O'Gorman MRG, Donnenbeg AD. Handbook of human immunology. 2ª ed. Boca Raton: CRC, 2008. p. 313-8. ISBN 978-0-8493-1984-6. REPERTORIO DO RECEPTOR DE CELULAS T; T-CELL RECEPTOR DE ANTIGENIO; REACAO EM CADEIA DA POLIMERASE QUANTITATIVA; SPECTRATYPING |
| 158/344 | US=39 / Câncer Daniels TR, Neacato IL, Helguera G, Penichet ML. Targeting the transferrin receptor to overcome resistance to anti-cancer agents. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 13-27. ISBN 978-1-58829-989-5. RECEPTORES-ALVO; TRANSFERRINA; AGENTES ANTICANCERIGENOS; QUIMIORRESISTENCIA |
| 159/344 | US=18 / Pediatria Huntchison RE, Uner A. Biology and pathology of Hodgkin's Disease. In: Weinstein HJ, Hudson MM, Link MP. Pediatric lymphomas. New York: Springer Verlag, 2008. p. 7-33. (Pediatric Oncology) ISBN 978-3-540-20356-8. DOENCA DE HODGKIN; DE NECROSE TUMORAL DA FAMILIA DO RECEPTOR DO FACTOR; CITOCINAS; QUIMIOCINAS; CITOGENETICA; PERFIL GENETICO; LINFOMA DE HODGKIN CLASSICO; LINFOCITOS NODULAR; LINFOCITOS EMPOBRECIDO; NODULAR LINFOCITO LINFOMA DE HODGKIN PREDOMINANTE |
| 160/344 | Câncer Schiavon BN, Vassallo J, Rocha RM. Is polysomy 17 an important phenomenon to predict treatment with trastuzumab in breast cancer ?. Applied Cancer Research, São Paulo: Tecmedd, v.31, n.4, p. 138-42, 2011. ISSN 1980-5578. Disponível em: http://accamargo.phlnet.com.br/applied/ACR2011;31p.138-42.pdf NEOPLASIAS DA MAMA; HER-2; HIBIDIZACAO; POLISOME; TRASTUZUMAB; FLUORESCENCIA |